Weekly Update

Are Analysts Optimistic About Where Medivation, Inc. (NASDAQ:MDVN) is Heading?

Wall Street is predicting that Medivation, Inc. (NASDAQ:MDVN)’s earnings per share (EPS) will be $N/A when the firm is expected to announce earnings around N/A. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each share[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Zumiez Inc. (NASDAQ:ZUMZ) is Heading?

Wall Street is predicting that Zumiez Inc. (NASDAQ:ZUMZ)’s earnings per share (EPS) will be $0.67 when the firm is expected to announce earnings around 2017-03-09. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each share[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is Heading?

Wall Street is predicting that Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s earnings per share (EPS) will be $-1.26 when the firm is expected to announce earnings around 2017-02-28. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Texas Roadhouse, Inc. (NASDAQ:TXRH) is Heading?

Wall Street is predicting that Texas Roadhouse, Inc. (NASDAQ:TXRH)’s earnings per share (EPS) will be $0.38 when the firm is expected to announce earnings around 2017-02-21. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where USA Technologies, Inc. (NASDAQ:USAT) is Heading?

Wall Street is predicting that USA Technologies, Inc. (NASDAQ:USAT)’s earnings per share (EPS) will be $0 when the firm is expected to announce earnings around 2017-05-11. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Luminex Corporation (NASDAQ:LMNX) is Heading?

Wall Street is predicting that Luminex Corporation (NASDAQ:LMNX)’s earnings per share (EPS) will be $0.11 when the firm is expected to announce earnings around 2017-05-01. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each share[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Cross Country Healthcare, Inc. (NASDAQ:CCRN) is Heading?

Wall Street is predicting that Cross Country Healthcare, Inc. (NASDAQ:CCRN)’s earnings per share (EPS) will be $0.21 when the firm is expected to announce earnings around 2017-03-01. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is Heading?

Wall Street is predicting that Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)’s earnings per share (EPS) will be $-0.45 when the firm is expected to announce earnings around 2017-03-06. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where China Biologic Products, Inc. (NASDAQ:CBPO) is Heading?

Wall Street is predicting that China Biologic Products, Inc. (NASDAQ:CBPO)’s earnings per share (EPS) will be $0.84 when the firm is expected to announce earnings around 2017-02-23. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to[Read More…]

by February 20, 2017 0 comments Weekly Update

Are Analysts Optimistic About Where Vital Therapies, Inc. (NASDAQ:VTL) is Heading?

Wall Street is predicting that Vital Therapies, Inc. (NASDAQ:VTL)’s earnings per share (EPS) will be $-0.33 when the firm is expected to announce earnings around 2017-03-14. Zacks Research, a leading equity research firm for over 30 years, provides the consensus number. The definition of earnings per share (EPS) means that it is the portion of a profit given to each[Read More…]

by February 20, 2017 0 comments Weekly Update